These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28228336)

  • 21. A DNA-Modified Live Vaccine Prime-Boost Strategy Broadens the T-Cell Response and Enhances the Antibody Response against the Porcine Reproductive and Respiratory Syndrome Virus.
    Bernelin-Cottet C; Urien C; Stubsrud E; Jakob V; Bouguyon E; Bordet E; Barc C; Boulesteix O; Contreras V; Barnier-Quer C; Collin N; Trus I; Nauwynck H; Bertho N; Schwartz-Cornil I
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31207934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of immunizations with porcine reproductive and respiratory syndrome virus on lymphoproliferative recall responses of CD8+ T cells.
    Bassaganya-Riera J; Thacker BJ; Yu S; Strait E; Wannemuehler MJ; Thacker EL
    Viral Immunol; 2004; 17(1):25-37. PubMed ID: 15018660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune response and protective efficacy of intramuscular and intradermal vaccination with porcine reproductive and respiratory syndrome virus 1 (PRRSV-1) modified live vaccine against highly pathogenic PRRSV-2 (HP-PRRSV-2) challenge, either alone or in combination with of PRRSV-1.
    Madapong A; Saeng-Chuto K; Chaikhumwang P; Tantituvanont A; Saardrak K; Pedrazuela Sanz R; Miranda Alvarez J; Nilubol D
    Vet Microbiol; 2020 May; 244():108655. PubMed ID: 32402335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A DNA Prime Immuno-Potentiates a Modified Live Vaccine against the Porcine Reproductive and Respiratory Syndrome Virus but Does Not Improve Heterologous Protection.
    Bernelin-Cottet C; Urien C; Fretaud M; Langevin C; Trus I; Jouneau L; Blanc F; Leplat JJ; Barc C; Boulesteix O; Riou M; Dysart M; Mahé S; Studsrub E; Nauwynck H; Bertho N; Bourry O; Schwartz-Cornil I
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31242645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasal immunization of pigs with porcine reproductive and respiratory syndrome virus-like particles plus 2', 3'-cGAMP VacciGrade™ adjuvant exacerbates viremia after virus challenge.
    Van Noort A; Nelsen A; Pillatzki AE; Diel DG; Li F; Nelson E; Wang X
    Virol J; 2017 Apr; 14(1):76. PubMed ID: 28403874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmid containing CpG oligodeoxynucleotides can augment the immune responses of pigs immunized with porcine reproductive and respiratory syndrome killed virus vaccine.
    Quan Z; Qin ZG; Zhen W; Feng XZ; Hong J; Fei ZH
    Vet Immunol Immunopathol; 2010 Aug; 136(3-4):257-64. PubMed ID: 20394988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of a recombinant adenovirus expressing porcine reproductive and respiratory syndrome virus polyepitopes.
    Hernández J; Rascón-Castelo E; Bray J; Lokhandwala S; Mwangi W
    Vet Microbiol; 2017 Dec; 212():7-15. PubMed ID: 29173591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivated porcine reproductive and respiratory syndrome virus vaccine adjuvanted with Montanide™ Gel 01 ST elicits virus-specific cross-protective inter-genotypic response in piglets.
    Tabynov K; Sansyzbay A; Tulemissova Z; Tabynov K; Dhakal S; Samoltyrova A; Renukaradhya GJ; Mambetaliyev M
    Vet Microbiol; 2016 Aug; 192():81-89. PubMed ID: 27527768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discriminating between serological responses to European-genotype live vaccine and European-genotype field strains of porcine reproductive and respiratory syndrome virus (PRRSV) by peptide ELISA.
    Oleksiewicz MB; Stadejek T; Maćkiewicz Z; Porowski M; Pejsak Z
    J Virol Methods; 2005 Nov; 129(2):134-44. PubMed ID: 15992937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic Characterization of Porcine IFNγ-Producing Lymphocytes in Porcine Reproductive and Respiratory Syndrome Virus Vaccinated and Challenged Pigs.
    Li X; Pei Z; Bai Y; Wang L; Shi J; Tian K
    Virol Sin; 2018 Dec; 33(6):524-530. PubMed ID: 30560415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pigs that recover from porcine reproduction and respiratory syndrome virus infection develop cytotoxic CD4+CD8+ and CD4+CD8- T-cells that kill virus infected cells.
    Chung CJ; Cha SH; Grimm AL; Ajithdoss D; Rzepka J; Chung G; Yu J; Davis WC; Ho CS
    PLoS One; 2018; 13(9):e0203482. PubMed ID: 30188946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
    Zhang Z; Wang Y; Fan H; Lu C
    Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
    Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
    Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus replicon particles expressing porcine reproductive and respiratory syndrome virus proteins elicit immune priming but do not confer protection from viremia in pigs.
    Eck M; Durán MG; Ricklin ME; Locher S; Sarraseca J; Rodríguez MJ; McCullough KC; Summerfield A; Zimmer G; Ruggli N
    Vet Res; 2016 Feb; 47():33. PubMed ID: 26895704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
    Tian D; Sooryanarain H; Matzinger SR; Gauger PC; Karuppannan AK; Elankumaran S; Opriessnig T; Meng XJ
    J Gen Virol; 2017 Dec; 98(12):3026-3036. PubMed ID: 29091579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteome-wide screening of the European porcine reproductive and respiratory syndrome virus reveals a broad range of T cell antigen reactivity.
    Mokhtar H; Eck M; Morgan SB; Essler SE; Frossard JP; Ruggli N; Graham SP
    Vaccine; 2014 Nov; 32(50):6828-37. PubMed ID: 24844151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive inductive effect of swine interleukin-4 on immune responses elicited by modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine.
    Peng J; Wang J; Wu J; Du Y; Li J; Guo Z; Yu J; Xu S; Zhang Y; Sun W; Cong X; Shi J
    Viral Immunol; 2013 Dec; 26(6):404-14. PubMed ID: 24328935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological response to porcine reproductive and respiratory syndrome virus in young pigs obtained from a PRRSV-positive exposure status herd in a PRRSV endemic area.
    Kittiwan N; Yamsakul P; Tadee P; Tadee P; Nuangmek A; Chuammitri P; Patchanee P
    Vet Immunol Immunopathol; 2019 Dec; 218():109935. PubMed ID: 31562984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-protection of a new type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccine (Fostera PRRS) against heterologous type 1 PRRSV challenge in growing pigs.
    Park C; Choi K; Jeong J; Chae C
    Vet Microbiol; 2015 May; 177(1-2):87-94. PubMed ID: 25769646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
    Jeong J; Kang I; Kim S; Park SJ; Park KH; Oh T; Yang S; Chae C
    Transbound Emerg Dis; 2018 Oct; 65(5):1227-1234. PubMed ID: 29536637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.